Organizations and the Bioeconomy
The Management and Commodification of the Life Sciences
Seiten
2012
Routledge (Verlag)
978-0-415-52926-6 (ISBN)
Routledge (Verlag)
978-0-415-52926-6 (ISBN)
This book presents an integrated yet complex view of how the life sciences are becoming increasingly subject to economic interests and venturing. Not only are life science advances confined to laboratories—only slowly and eventually pouring into the health care practices, policies, and recommendations—but they are also taking the form of goods and services in their own right.
The advancement of the life sciences and the technosciences has enhanced the longevity of citizens in the Western world, and half of the generation born in the first decade of the new millennium is now expected to live to the age of one hundred years. In a society with such longevity and affluence, consumption of health-related goods and services such as pharmaceuticals and scanning procedures may be seen as a sustainable source of income for the industries that promote it. Though the healthcare sector has traditionally been organized in the public sector in Europe and in the private sector in the US, the recent advancement of new therapies and direct-to-consumer marketing have opened up new streams of consumption and revenue for health care goods and services around the globe.
This book examines the so-called ‘bioeconomy’ as a new economic and commercial field that emphasizes the management of individual life, including the regulation and control of weight and food consumption and other issues pertaining to individual well-being. In addition, the bioeconomy includes a variety of practices based on commercial interests such as organ donations, reproductive medicine and technologies, and what has been referred to as the tissue economy – the various forms of trade with human tissues. Author Alexander Styhre provides a thorough introduction to the bioeconomy, exploring this new and unique intersection of the life sciences and the technosciences with more traditional consumer markets.
The advancement of the life sciences and the technosciences has enhanced the longevity of citizens in the Western world, and half of the generation born in the first decade of the new millennium is now expected to live to the age of one hundred years. In a society with such longevity and affluence, consumption of health-related goods and services such as pharmaceuticals and scanning procedures may be seen as a sustainable source of income for the industries that promote it. Though the healthcare sector has traditionally been organized in the public sector in Europe and in the private sector in the US, the recent advancement of new therapies and direct-to-consumer marketing have opened up new streams of consumption and revenue for health care goods and services around the globe.
This book examines the so-called ‘bioeconomy’ as a new economic and commercial field that emphasizes the management of individual life, including the regulation and control of weight and food consumption and other issues pertaining to individual well-being. In addition, the bioeconomy includes a variety of practices based on commercial interests such as organ donations, reproductive medicine and technologies, and what has been referred to as the tissue economy – the various forms of trade with human tissues. Author Alexander Styhre provides a thorough introduction to the bioeconomy, exploring this new and unique intersection of the life sciences and the technosciences with more traditional consumer markets.
Alexander Styhre is Professor and Chair of Organization Theory and Management in the Department of Business Administration, School of Business, Economics, and Law at Gothenburg University, Sweden. He has published extensively in the field of organization theory and his most recent books are Visual Culture in Organizations (Routledge, 2010) and Perception and Organization (2009).
Selected Contents: 1. The Concept of the Bioeconomy 2. Biopolitics, Neoliberalism, and the Calculative Worldview: The Economics of Life 3. New Drug Development, Biotechnology and the Enactment of Life 4. The Tissue Economy 5. Living In and Managing the Bioeconomy
| Erscheint lt. Verlag | 14.6.2012 |
|---|---|
| Reihe/Serie | Routledge Studies in Management, Organizations and Society |
| Zusatzinfo | 1 Tables, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 540 g |
| Themenwelt | Medizin / Pharmazie ► Gesundheitswesen |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Studium ► Querschnittsbereiche ► Geschichte / Ethik der Medizin | |
| Wirtschaft ► Betriebswirtschaft / Management ► Marketing / Vertrieb | |
| Wirtschaft ► Betriebswirtschaft / Management ► Planung / Organisation | |
| Wirtschaft ► Volkswirtschaftslehre | |
| ISBN-10 | 0-415-52926-3 / 0415529263 |
| ISBN-13 | 978-0-415-52926-6 / 9780415529266 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Die Geschichte eines Weltzentrums der Medizin von 1710 bis zur …
Buch | Softcover (2021)
Lehmanns Media (Verlag)
CHF 27,90
von der Antike bis zur Gegenwart
Buch | Softcover (2024)
C.H.Beck (Verlag)
CHF 16,80
Krankheitslehren, Irrwege, Behandlungsformen
Buch | Softcover (2024)
C.H.Beck (Verlag)
CHF 55,90
